Fig 1.
(A) Lobular cancer. (B) Ductal cancer. (C)Medullary cancer.
Table 1.
Characteristics of the Patients (n = 156).
Fig 2.
Immunohistochemical analysis of p53 and Ki-67 in TNBC.
(A) Negative and positive p53 staining. (B) Negative and positive Ki-67 staining.
Fig 3.
P53 and Ki-67 associates with tumor grade in TNBC.
Box plots indicating the distribution of the p53 (A) and Ki-67 (B) and tumor grade, P values were from one-way ANOVA and LSD tests. (C) P53 and Ki-67 was associated with tumor grade in TNBC. (D) P53 was associated with Ki-67 in TNBC. The R and P values were from Pearson Correlation.
Table 2.
Expression of p53 positivity/Ki-67 high index in each characteristic.
Fig 4.
P53, Ki-67 and family history predict survival in TNBC.
Estimated disease-free survival (DFS) (A) and overall survival (OS) (B) curves for p53, Ki-67 and family history.
Table 3.
Logistic regression analysis of factors predicting recurrence.
Table 4.
Univariate and multivariate survival analysis for disease-free survival.
Table 5.
Univariate and multivariate survival analysis for overall survival.